News & Updates

Dexmedetomidine leads to quicker GI recovery after laparoscopic hysteromyomectomy

06 Sep 2022 by

In patients undergoing laparoscopic hysteromyomectomy, intraoperative intravenous use of dexmedetomidine may help ease postoperative ileus, hastening the recovery of gastrointestinal (GI) function after operation, according to a recent study.

Dexmedetomidine leads to quicker GI recovery after laparoscopic hysteromyomectomy

06 Sep 2022

Original New Drug Application Approvals by US FDA (16 - 31 August 2022)

05 Sep 2022

New drug applications approved by US FDA as of 16 - 31 August 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16 - 31 August 2022)

05 Sep 2022

Incidence of peptic ulcer disease decreasing globally

04 Sep 2022

Peptic ulcer disease (PUD) is still a major cause of hospitalization across the globe, but PUD-related hospitalizations and mortality have been on the decline in many countries belonging to the Organisation for Economic Co-operation and Development (OECD) across Asia, Europe, Oceania, North America, and Latin America, reports a study.

Incidence of peptic ulcer disease decreasing globally

04 Sep 2022

Persistent-positive coeliac serology tied to hypothyroidism risk

04 Sep 2022

Persistent-positive coeliac serology appears to predict the risk of hypothyroidism among the paediatric population, according to a study.

Persistent-positive coeliac serology tied to hypothyroidism risk

04 Sep 2022

Estrogen replacement therapy tied to lower risk of gastric, colorectal cancers

03 Sep 2022

The use of estrogen replacement therapy appears to yield a risk-lowering effect on gastric and colorectal cancers, as reported in a retrospective study.

Estrogen replacement therapy tied to lower risk of gastric, colorectal cancers

03 Sep 2022

Poor adherence to treatments persists in many adult patients with eosinophilic esophagitis

03 Sep 2022

Several adult patients with eosinophilic esophagitis (EoE) poorly adhere to their maintenance treatment, a recent study has found.

Poor adherence to treatments persists in many adult patients with eosinophilic esophagitis

03 Sep 2022

Synbiotics safe, effective at cutting uraemic toxins in CKD

02 Sep 2022

Patients with chronic kidney disease (CKD) can safely use synbiotics to reduce their levels of uraemic toxins and minimize microinflammation, reports a new study.

Synbiotics safe, effective at cutting uraemic toxins in CKD

02 Sep 2022

AI-assisted colonoscopy improves polyp detection

01 Sep 2022 by

Artificial intelligence (AI)–assisted colonoscopy improves adenoma detection in asymptomatic individuals undergoing colorectal cancer (CRC) screening, a multicentre randomized controlled trial (RCT) has shown.

AI-assisted colonoscopy improves polyp detection

01 Sep 2022

Anti-GMAbs predict Crohn’s disease years before diagnosis

31 Aug 2022 by

The presence of autoantibodies against the granulocyte macrophage-colony stimulating factor (aGMAb) appears to precede Crohn’s disease (CD) diagnosis by years, according to a recent study. AGMAbs could be used for the prediction of complicated CD.

Anti-GMAbs predict Crohn’s disease years before diagnosis

31 Aug 2022

Second-line NIVO + IPI combo sustains response, OS benefit in aHCC

30 Aug 2022 by

The combination of nivolumab 1 mg/kg (NIVO1) and ipilimumab 3 mg/kg (IPI3) every 3 weeks followed by NIVO 240 mg every 2 weeks in the second-line setting continues to confer durable response and overall survival (OS) benefit in patients with advanced hepatocellular carcinoma (aHCC), according to 5-year data from the CheckMate 040* trial presented at ESMO GI 2022.

Second-line NIVO + IPI combo sustains response, OS benefit in aHCC

30 Aug 2022

News & Updates

Filter by Specialty:

Specialty:

Dexmedetomidine leads to quicker GI recovery after laparoscopic hysteromyomectomy

Dexmedetomidine leads to quicker GI recovery after laparoscopic hysteromyomectomy

Original New Drug Application Approvals by US FDA (16 - 31 August 2022)

Original New Drug Application Approvals by US FDA (16 - 31 August 2022)

Incidence of peptic ulcer disease decreasing globally

Incidence of peptic ulcer disease decreasing globally

Persistent-positive coeliac serology tied to hypothyroidism risk

Persistent-positive coeliac serology tied to hypothyroidism risk

Estrogen replacement therapy tied to lower risk of gastric, colorectal cancers

Estrogen replacement therapy tied to lower risk of gastric, colorectal cancers

Poor adherence to treatments persists in many adult patients with eosinophilic esophagitis

Poor adherence to treatments persists in many adult patients with eosinophilic esophagitis

Synbiotics safe, effective at cutting uraemic toxins in CKD

Synbiotics safe, effective at cutting uraemic toxins in CKD

AI-assisted colonoscopy improves polyp detection

AI-assisted colonoscopy improves polyp detection

Anti-GMAbs predict Crohn’s disease years before diagnosis

Anti-GMAbs predict Crohn’s disease years before diagnosis

Second-line NIVO + IPI combo sustains response, OS benefit in aHCC

Second-line NIVO + IPI combo sustains response, OS benefit in aHCC